JACOB BARTON: Open Payments
NPI 1295283067 · CAMERON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 51 payments from 13 companies in 2025. Trend: 2023 $443 · 2024 $664 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $124 |
| Lilly USA, LLC | 6 | $113 |
| Viatris Specialty LLC | 5 | $96 |
| ABBVIE INC. | 4 | $80 |
| Astellas Pharma US Inc | 3 | $70 |
| Novo Nordisk Inc | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Axsome Therapeutics, Inc. | 3 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
Products named: FANAPT, CAPLYTA, YUPELRI, MOUNJARO, Veozah, REXULTI, Auvelity, UBRELVY.
Industry payments across MO — which companies pay providers there.
